The association between human papillomavirus and bladder cancer: Evidence from meta‐analysis and two‐sample mendelian randomization

• Published in: Journal of medical virology Vol. 95; no. 1; pp. e28208 - n/a
• Main Authors: Sun, Jian‐Xuan, Xu, Jin‐Zhou, Liu, Chen‐Qian, An, Ye, Xu, Meng‐Yao, Zhong, Xing‐Yu, Zeng, Na, Ma, Si‐Yang, He, Hao‐Dong, Hu, Jia, Liu, Zheng, Wang, Shao‐Gang, Xia, Qi‐Dong
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.01.2023; John Wiley and Sons Inc
• Subjects: Bibliographic data bases; Bibliographies; Bladder; Bladder cancer; Cancer; Carcinogenesis; Carcinogens; E7 protein; Genetic diversity; Genetic variance; Health risks; HPV prevalence; Human papillomavirus; Human papillomavirus 18; Human Papillomavirus Viruses; Humans; Infections; Male; mendelian randomization; Mendelian Randomization Analysis; Meta-analysis; Papillomaviridae - genetics; Papillomavirus Infections - complications; Papillomavirus Infections - epidemiology; Papillomavirus Infections - prevention & control; Prognosis; Proteins; Randomization; Review; Reviews; Risk; Sexually transmitted diseases; STD; Urinary Bladder Neoplasms - complications; Urinary Bladder Neoplasms - epidemiology; Vaccination; Virology; meta-analysis; HPV prevalence; bladder cancer; mendelian randomization; human papillomavirus
• ISSN: 0146-6615; 1096-9071; 1096-9071
• DOI: 10.1002/jmv.28208

Introduction Bladder cancer (BCa) is the 10th most common type of cancer worldwide, and human papillomavirus (HPV) is the most common sexually transmitted infection. However, the relationship between HPV infection and the risk of BCa is still controversial and inconclusive. Methods This systematic review and meta‐analysis were conducted following the PRISMA 2020 reporting guideline. This study searched four bibliographic databases with no language limitation. The databases included PubMed (Medline), EMBASE, Cochrane Library, and Web of Science. Studies evaluating the interaction between HPV infection and the risk of BCa from inception through May 21, 2022, were identified and used in this study. This study estimated the overall and type‐specific HPV prevalence and 95% confidence intervals (95% CI) using Random Effects models and Fixed Effects models. In addition, this study also calculated the pooled odds ratio and pooled risk ratio with 95% CI to assess the effect of HPV infection on the risk and prognosis of bladder cancer. Two‐sample mendelian randomization (MR) study using genetic variants associated with HPV E7 protein as instrumental variables were also conducted. Results This study retrieved 80 articles from the four bibliographic databases. Of the total, 27 were case–control studies, and 53 were cross‐sectional studies. The results showed that the prevalence of HPV was 16% (95% CI: 11%–21%) among the BCa patients, most of which were HPV‐16 (5.99% [95% CI: 3.03%–9.69%]) and HPV‐18 (3.68% [95% CI: 1.72%–6.16%]) subtypes. However, the study found that the prevalence varied by region, detection method, BCa histological type, and sample source. A significantly increased risk of BCa was shown for the positivity of overall HPV (odds ratio [OR], 3.35 [95% CI: 1.75–6.43]), which was also influenced by study region, detection method, histological type, and sample source. In addition, the study found that HPV infection was significantly associated with the progression of BCa (RR, 1.73 [95% CI: 1.39–2.15]). The two‐sample MR analysis found that both HPV 16 and 18 E7 protein exposure increased the risk of BCa (HPV 16 E7 protein: IVW OR per unit increase in protein level = 1.0004 [95% CI: 1.0002–1.0006]; p = 0.0011; HPV 18 E7 protein: IVW OR per unit increase in protein level = 1.0003 [95% CI: 1.0001–1.0005]; p = 0.0089). Conclusion In conclusion, HPV may play a role in bladder carcinogenesis and contribute to a worse prognosis for patients with BCa. Therefore, it is necessary for people, especially men, to get vaccinated for HPV vaccination to prevent bladder cancer.